AngioDynamics (ANGO) Earnings Date, Estimates & Call Transcripts $10.26 +0.13 (+1.28%) Closing price 04:00 PM EasternExtended Trading$10.33 +0.07 (+0.68%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock AngioDynamics Earnings Summary AngioDynamics released Q4 2025 earnings on July 15, 2025, reporting an EPS of -$0.03, which beat analysts' consensus estimates of -$0.12 by $0.09. Quarterly revenue rose 13.0% year-over-year to $80.16 million, above the consensus estimate of $74.26 million. With a trailing EPS of -$0.83, AngioDynamics' earnings are expected to grow next year, from ($0.37) to ($0.26) per share. Upcoming Q1 Earnings DateOct. 2Before Market OpensEstimatedConsensus EPS (Jul. 15) -$0.12 Actual EPS (Jul. 15) -$0.03 Beat By $0.09 Actual Revenue (Jul. 15) $80.16MQ4 2025 Earnings ResourcesQ4 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Slide Deck Annual Report (10-K)SEC FilingANGO Upcoming EarningsAngioDynamics' next earnings date is estimated for Thursday, October 2, 2025, based on past reporting schedules. Slide DeckFull Screen Slide DeckPowered by Get AngioDynamics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on AngioDynamics and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataANGO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ANGO Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. AngioDynamics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue GuidanceQ1 20252-$0.15-$0.13-$0.14Q2 20252-$0.12-$0.10-$0.11Q3 20252-$0.11-$0.10-$0.11Q4 20252-$0.20-$0.09-$0.15 FY 2025 8 -$0.58 -$0.42 -$0.50 Q1 20262-$0.14-$0.14-$0.14Q2 20262-$0.10-$0.10-$0.10Q3 20262-$0.08-$0.08-$0.08Q4 20262$0.01$0.02$0.02 FY 2026 8 -$0.31 -$0.30 -$0.31 Q1 20271-$0.11-$0.11-$0.11Q2 20271-$0.03-$0.03-$0.03Q4 20271$0.00$0.00$0.00 AngioDynamics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 10/2/2025(Estimated)--------7/15/2025Q4 2025-$0.12-$0.03+$0.09-$0.15$74.26M$80.16M4/2/2025Q3 2025-$0.13$0.03+$0.16-$0.11$70.30M$72.00M1/8/2025Q2 2025-$0.11-$0.04+$0.07-$0.26$70.93M$72.90M10/3/2024Q1 2025-$0.15-$0.11+$0.04$0.09$67.93M$67.50M7/16/2024Q4 2024-$0.17-$0.06+$0.11$0.21$70.86M$71.00M4/4/2024Q3 2024-$0.14-$0.16 -$0.02$4.41$76.71M$75.18M1/5/2024Q2 2024-$0.09-$0.05+$0.04$0.62$81.65M$79.07M10/4/2023Q1 2024-$0.13-$0.12+$0.01-$1.39$77.70M$78.70M AngioDynamics Earnings - Frequently Asked Questions When is AngioDynamics' earnings date? AngioDynamics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 2nd, 2025 based off last year's report dates. Learn more on ANGO's earnings history. What guidance has AngioDynamics issued on next quarter's earnings? AngioDynamics issued an update on its FY 2026 earnings guidance on Tuesday, July, 15th. The company provided EPS guidance of -0.350--0.250 for the period, compared to the consensus EPS estimate of -0.227. The company issued revenue guidance of $305.0 million-$310.0 million, compared to the consensus revenue estimate of $304.9 million. Did AngioDynamics beat their earnings estimates last quarter? In the previous quarter, AngioDynamics (NASDAQ:ANGO) reported ($0.03) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.12) by $0.09. Learn more on analysts' earnings estimate vs. ANGO's actual earnings. How can I listen to AngioDynamics' earnings conference call? The conference call for AngioDynamics' latest earnings report can be listened to online. Listen to Conference Call How can I read AngioDynamics' conference call transcript? The conference call transcript for AngioDynamics' latest earnings report can be read online. Read Transcript How can I view AngioDynamics' earnings report? AngioDynamics' earnings report can be found in their filing with the SEC. View SEC filing How much revenue does AngioDynamics generate each year? AngioDynamics (NASDAQ:ANGO) has a recorded annual revenue of $292.50 million. How much profit does AngioDynamics generate each year? AngioDynamics (NASDAQ:ANGO) has a recorded net income of -$33.99 million. ANGO has generated -$0.83 earnings per share over the last four quarters. What is AngioDynamics' EPS forecast for next year? AngioDynamics' earnings are expected to grow from ($0.37) per share to ($0.26) per share in the next year. More Earnings Resources from MarketBeat Related Companies Thermo Fisher Scientific Earnings Results West Pharmaceutical Services Earnings Results Integra LifeSciences Earnings Results Orthofix Medical Earnings Results Surmodics Earnings Results Accuray Earnings Results Rockwell Medical Earnings Results ReShape Lifesciences Earnings Results Abbott Laboratories Earnings Results Intuitive Surgical Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost Pressures This page (NASDAQ:ANGO) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AngioDynamics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AngioDynamics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access